Acadia Healthcare (NASDAQ:ACHC) Price Target Lowered to $43.00 at Royal Bank of Canada

Acadia Healthcare (NASDAQ:ACHC) had its price target lowered by Royal Bank of Canada from $64.00 to $43.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

ACHC has been the topic of a number of other reports. TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, KeyCorp cut their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Hold” and an average target price of $56.31.

Acadia Healthcare Trading Down 2.4 %

Acadia Healthcare stock opened at $29.26 on Monday. The stock has a market capitalization of $2.72 billion, a PE ratio of 9.59, a price-to-earnings-growth ratio of 1.46 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a 12-month low of $29.19 and a 12-month high of $86.56. The firm has a 50 day simple moving average of $41.93 and a 200-day simple moving average of $51.32.

Institutional Trading of Acadia Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the company. Public Employees Retirement System of Ohio acquired a new stake in shares of Acadia Healthcare during the 4th quarter valued at about $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Acadia Healthcare by 22.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company’s stock valued at $12,439,000 after acquiring an additional 56,647 shares in the last quarter. Voloridge Investment Management LLC acquired a new stake in Acadia Healthcare in the fourth quarter valued at approximately $15,770,000. Squarepoint Ops LLC bought a new stake in Acadia Healthcare in the fourth quarter worth approximately $1,087,000. Finally, Two Sigma Investments LP acquired a new position in shares of Acadia Healthcare during the 4th quarter worth $7,648,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.